A detailed history of Jane Street Group, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 2,671,269 shares of PACB stock, worth $5.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,671,269
Previous 1,704,491 56.72%
Holding current value
$5.21 Million
Previous $2.34 Million 94.48%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.17 $1.16 Million - $2.1 Million
966,778 Added 56.72%
2,671,269 $4.54 Million
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $1.61 Million - $4.32 Million
1,183,680 Added 227.28%
1,704,491 $2.34 Million
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $118,363 - $322,473
33,626 Added 6.9%
520,811 $1.95 Million
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $1.41 Million - $2.45 Million
236,487 Added 94.33%
487,185 $4.78 Million
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $241,171 - $408,204
-29,304 Reduced 10.47%
250,698 $2.09 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $2.03 Million - $2.86 Million
203,620 Added 266.58%
280,002 $3.72 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $1.47 Million - $2.23 Million
-185,179 Reduced 70.8%
76,382 $884,000
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $105,144 - $207,692
-18,544 Reduced 6.62%
261,561 $2.14 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $584,945 - $1.28 Million
148,841 Added 113.39%
280,105 $1.63 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $584,945 - $1.28 Million
148,841 Added 113.39%
280,105 $1.63 Million
Q2 2022

Aug 16, 2022

BUY
$4.02 - $10.43 $216,243 - $561,050
53,792 Added 69.43%
131,264 $580,000
Q1 2022

May 17, 2022

SELL
$8.43 - $20.9 $1.19 Million - $2.95 Million
-141,218 Reduced 64.57%
77,472 $705,000
Q4 2021

Feb 15, 2022

BUY
$19.26 - $30.08 $2.9 Million - $4.53 Million
150,518 Added 220.79%
218,690 $4.48 Million
Q3 2021

Nov 16, 2021

BUY
$24.86 - $35.02 $133,398 - $187,917
5,366 Added 8.54%
68,172 $1.74 Million
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $3.06 Million - $4.94 Million
-137,226 Reduced 68.6%
62,806 $2.2 Million
Q1 2021

May 18, 2021

SELL
$26.38 - $51.15 $72,808 - $141,174
-2,760 Reduced 1.36%
200,032 $6.66 Million
Q4 2020

Feb 17, 2021

BUY
$10.5 - $28.5 $1.58 Million - $4.3 Million
150,736 Added 289.57%
202,792 $5.26 Million
Q3 2020

Nov 17, 2020

BUY
$3.61 - $9.87 $126,501 - $345,864
35,042 Added 205.96%
52,056 $514,000
Q2 2020

Aug 17, 2020

BUY
$2.65 - $4.03 $45,087 - $68,566
17,014 New
17,014 $58,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $163,694 - $364,844
-69,362 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $140,286 - $169,868
30,497 Added 78.47%
69,362 $357,000
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $193,936 - $239,408
38,865 New
38,865 $201,000
Q3 2018

Nov 14, 2018

SELL
$3.52 - $5.55 $43,855 - $69,147
-12,459 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$2.11 - $3.92 $26,288 - $48,839
12,459 New
12,459 $44,000
Q1 2018

May 15, 2018

SELL
$2.05 - $3.23 $31,852 - $50,187
-15,538 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$2.59 - $5.44 $367 - $772
-142 Reduced 0.91%
15,538 $41,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $50,176 - $87,337
15,680
15,680 $82,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.